Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-02-03

FDA Approved: REVATIO — Supplemental Application (PFIZER LABORATORIES DIV PFIZER INC)

View source ↗

Summary

FDA approved a supplemental application for Revatio (sildenafil citrate) by Pfizer Laboratories Division Pfizer Inc, resulting in an approved update to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)